3[1]Watanabe Y,et al. OK-432,Clinical,PP.120,1984,Editors:Hoshino,T. ,et al,Printed in Japan
4[2]Sawai,k.et al. The 14th International Congress of Chemotherapy. Kyoto, June, 1985. Atracts: P-29-53
5[3]Uchida,A. ,et al: Int.J.Cancer,31,1,1983.OK-432,A Streptococcal Preparation as a potent Biological Response Modifier. Editors:Ishida,N.,et al.PP44,1983,Printed in Japan
7Noriaki Tanaka, Akira Gouchi, Toshinori Ohara. Intraumoral injection of astreprococcal preparation, OK-432, before surgery for gastric cancer. Cancer, 1994,1574(12):3097-3103.
5Das AK,Sato M ,Story MD,et al. Non-small-cell lung cancers with kinase domain mutations in the epidermal growth factor receptor are sensitive to ionizing radiation [ J ]. Cancer Res, 2006 ; 66 ( 19 ) : 9601-8.
6Bessho Y, Oguri T, Achiwa H, et al. Role of ABCG2 as a biomarker for predicting resistance to CPT-11/SN-38 in lung cancer[ J ]3Cancer Sci, 2006;97(3) :192-8.
7Guenova ML, Balatzenko GN, Nikolova VR,et al. An anti-apoptotic pat- tern correlates with multidrug resistance in acute myeloid leukemia pa- tients: a comparative study of active caspase-3, cleaved PARPs, Bcl-2, Survivin and MDR1 gene [ J ]. Hematology, 2010 ; 15 ( 3 ) : 135-43.
8Rashmi R, Kumar S, Karunagaran D. Human colon cancer cells lacking Bax resist cureumin-induced apoptosis and Bax requirement is dispensa- ble with ectopic expression of Smac or downregulation of Bcl-XL [J]. Carcinogenesis, 2005 ;26 ( 4 ) : 713-23.
10Harada K,Itashiki Y,Takenawa T,et al. Effects of lentinan alone and in combination with fluoropyrimidine anticancer agent on growth of human oral squamous cell carcinoma in vitro and in vivo[ J]. Int J Oncol, 2010, 37:623-631.
